Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2002
10/23/2002CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002CA2381875A1 Multioligoanilinated fullerenes
10/22/2002US6469207 Hiv protease inhibitors; administering to treat aids (acquired immune deficiency syndrome)
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia
10/17/2002WO2002081081A1 Composition based on an amine compound and ammonium bifluoride and use thereof
10/17/2002WO2002050081A3 Antimicrobial agents
10/17/2002WO2001096283A9 Hiv integrase inhibitors
10/17/2002US20020151734 12-HETrE analogs and methods of use thereof
10/17/2002US20020151548 Such as 2-((4-(4-(4-(Bis-carbamoylmethyl-sulfamoyl)-benzyl) -6-chloro-(1,3,5)triazin-2-ylmethyl)-benzenesulfonyl)-carbamoyl methyl-amino)acetamide; precipitation; crystallization
10/17/2002US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002US20020150545 Copper sulfat complexes to amino acid
10/17/2002DE10117823A1 New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0930292B1 Process for preparing beta-amino-alpha-hydroxy acid derivatives
10/16/2002EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/16/2002CN1374863A Bicyclic antagonists selective for the alpha beta integrin
10/16/2002CN1092630C Process for alkoxylation of fluorinated alcohols
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/10/2002WO2003084997A1 Probes, systems and methods for drug discovery
10/10/2002WO2002079122A2 Methods of synthesizing phenol-containing compounds
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002WO2002053516A3 N(phenylsulphonyl)glycine derivatives and their therapeutic use
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147191 Antiinflammatory agents, psychological disorders
10/10/2002US20020147182 13-substituted methacycline compounds
10/10/2002CA2442654A1 Probes, systems, and methods for drug discovery
10/10/2002CA2442480A1 Methods of synthesizing phenol-containing compounds
10/09/2002EP1248313A2 Polymer electrolyte and process for producing the same
10/09/2002EP1246797A1 Cyclopentyl sulfonamide derivatives
10/09/2002EP1246796A1 Process for the preparation of diphenyl ether compounds
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1092187C Herbicidal sulfonyl urea derivs
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/03/2002WO2002076968A1 Malonates as inhibitors of the ice/ced-6 family of cysteine proteases
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076932A1 Process for preparing amino compounds by using salen-manganese complexes as the catalyst
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076928A2 Alkylamine derivatives as antifouling agents
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076375A2 Process for the preparation of benazepril
10/03/2002WO2002030880A3 N-substituted amino acid derivatives (factor xa inhibitors)
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002CA2442573A1 Process for the preparation of benazepril
10/03/2002CA2441197A1 Alkylamine derivatives as antifouling agents
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245558A1 Alkylamine derivates as anti-fouling agents
10/02/2002EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244615A1 Method for producing n-substituted 2,4-diamino-5-fluoro benzonitriles and novel intermediates
10/02/2002EP1244610A1 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
10/02/2002EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
10/02/2002CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/01/2002US6459003 Ether compounds
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458960 Sulfonamide derivatives
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458845 Macrophage scavenger receptor antagonists
10/01/2002US6458815 Cardiovascular disorders, anticholesterol agent
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458776 Inflammatory bowel disease
10/01/2002CA2209018C Sulfonamides and their use
09/2002
09/26/2002WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137946 1-((4-halo-3-sulfonamidophenyl)aminocarbonyl),2-carboxy -pyrrolidine intermediate of given formula
09/26/2002US20020137942 HIV protease inhibitors; administering to treat AIDS (acquired immune deficiency syndrome)
09/26/2002US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/26/2002US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases
09/26/2002DE10112068A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site
09/26/2002CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/25/2002EP1243577A1 Novel phenylalanine derivatives
09/25/2002EP1242386A1 Nitro-sulfobenzamides
09/25/2002EP1242367A1 2-[3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors
09/25/2002EP1242363A2 Cd45 inhibitors
09/25/2002EP1000010B1 Nitration process for diphenyl ethers
09/25/2002EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 177